Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis

Abstract Background and Aim Because covert hepatic encephalopathy (CHE) has been shown to affect the prognosis of cirrhotic patients, early diagnosis of hepatic encephalopathy (HE) is a prerequisite for the preservation of patients' quality of life and for prophylaxis of overt HE. The aim of th...

Full description

Bibliographic Details
Main Authors: Kosuke Kaji, Kiwamu Okita, Kazuyuki Suzuki, Ikuya Sato, Masaki Fujisawa, Hitoshi Yoshiji
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:JGH Open
Subjects:
Online Access:https://doi.org/10.1002/jgh3.12468
_version_ 1818718613234778112
author Kosuke Kaji
Kiwamu Okita
Kazuyuki Suzuki
Ikuya Sato
Masaki Fujisawa
Hitoshi Yoshiji
author_facet Kosuke Kaji
Kiwamu Okita
Kazuyuki Suzuki
Ikuya Sato
Masaki Fujisawa
Hitoshi Yoshiji
author_sort Kosuke Kaji
collection DOAJ
description Abstract Background and Aim Because covert hepatic encephalopathy (CHE) has been shown to affect the prognosis of cirrhotic patients, early diagnosis of hepatic encephalopathy (HE) is a prerequisite for the preservation of patients' quality of life and for prophylaxis of overt HE. The aim of this study was to identify a clinical parameter to predict impairment of cognitive function in cirrhotic patients with early‐stage HE. Methods We investigated the data from 172 patients with cirrhotic or idiopathic portosystemic shunt (PSS) in phase II/III trials of rifaximin in Japan. Classification and regression trees (CARTs) were constructed to identify clinical profiles related to cognitive dysfunction as indicated by the prolongation of time required for the Number Connection Test (NCT‐B). Results CART analysis detected age 65 years as the variable for the initial split, and serum albumin level was selected as the variable for the second split among patients aged ≤65 years. In 27 cirrhotic patients aged ≤65 years without PSS, receiver operating characteristic curve analysis revealed that the optimal albumin level cutoff point was 3.05 g/dL, and the area under the curve was 0.80 for the prolongation of NCT‐B time, which was higher than that of the branched‐chain amino acids‐to‐tyrosine ratio (0.46), the prothrombin time–international normalized ratio (PT‐INR) (0.68), serum ammonia (0.61), and total bilirubin (0.69). Conclusions Lower serum albumin level as a clinical biomarker associated with impaired cognitive function may be available as a screening examination for early‐stage HE in cirrhotic patients aged ≤65 years without PSS before undergoing neuropsychological tests.
first_indexed 2024-12-17T19:53:50Z
format Article
id doaj.art-0a594a5be9ce4606b38d6a4a339129b0
institution Directory Open Access Journal
issn 2397-9070
language English
last_indexed 2024-12-17T19:53:50Z
publishDate 2021-02-01
publisher Wiley
record_format Article
series JGH Open
spelling doaj.art-0a594a5be9ce4606b38d6a4a339129b02022-12-21T21:34:38ZengWileyJGH Open2397-90702021-02-015220721210.1002/jgh3.12468Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysisKosuke Kaji0Kiwamu Okita1Kazuyuki Suzuki2Ikuya Sato3Masaki Fujisawa4Hitoshi Yoshiji5Department of Gastroenterology Nara Medical University Kashihara JapanShunan Memorial Hospital/Yamaguchi University Yamaguchi JapanDivision of Hepatology, Department of Internal Medicine Iwate Medical University Iwate JapanClinical Development Department ASKA Pharmaceutical Co., Ltd Tokyo JapanClinical Development Department ASKA Pharmaceutical Co., Ltd Tokyo JapanDepartment of Gastroenterology Nara Medical University Kashihara JapanAbstract Background and Aim Because covert hepatic encephalopathy (CHE) has been shown to affect the prognosis of cirrhotic patients, early diagnosis of hepatic encephalopathy (HE) is a prerequisite for the preservation of patients' quality of life and for prophylaxis of overt HE. The aim of this study was to identify a clinical parameter to predict impairment of cognitive function in cirrhotic patients with early‐stage HE. Methods We investigated the data from 172 patients with cirrhotic or idiopathic portosystemic shunt (PSS) in phase II/III trials of rifaximin in Japan. Classification and regression trees (CARTs) were constructed to identify clinical profiles related to cognitive dysfunction as indicated by the prolongation of time required for the Number Connection Test (NCT‐B). Results CART analysis detected age 65 years as the variable for the initial split, and serum albumin level was selected as the variable for the second split among patients aged ≤65 years. In 27 cirrhotic patients aged ≤65 years without PSS, receiver operating characteristic curve analysis revealed that the optimal albumin level cutoff point was 3.05 g/dL, and the area under the curve was 0.80 for the prolongation of NCT‐B time, which was higher than that of the branched‐chain amino acids‐to‐tyrosine ratio (0.46), the prothrombin time–international normalized ratio (PT‐INR) (0.68), serum ammonia (0.61), and total bilirubin (0.69). Conclusions Lower serum albumin level as a clinical biomarker associated with impaired cognitive function may be available as a screening examination for early‐stage HE in cirrhotic patients aged ≤65 years without PSS before undergoing neuropsychological tests.https://doi.org/10.1002/jgh3.12468albumincognitive dysfunctionhepatic encephalopathyliver cirrhosisportosystemic shunt
spellingShingle Kosuke Kaji
Kiwamu Okita
Kazuyuki Suzuki
Ikuya Sato
Masaki Fujisawa
Hitoshi Yoshiji
Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis
JGH Open
albumin
cognitive dysfunction
hepatic encephalopathy
liver cirrhosis
portosystemic shunt
title Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis
title_full Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis
title_fullStr Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis
title_full_unstemmed Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis
title_short Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis
title_sort association between serum albumin and cognitive dysfunction in hepatic encephalopathy an exploratory data analysis
topic albumin
cognitive dysfunction
hepatic encephalopathy
liver cirrhosis
portosystemic shunt
url https://doi.org/10.1002/jgh3.12468
work_keys_str_mv AT kosukekaji associationbetweenserumalbuminandcognitivedysfunctioninhepaticencephalopathyanexploratorydataanalysis
AT kiwamuokita associationbetweenserumalbuminandcognitivedysfunctioninhepaticencephalopathyanexploratorydataanalysis
AT kazuyukisuzuki associationbetweenserumalbuminandcognitivedysfunctioninhepaticencephalopathyanexploratorydataanalysis
AT ikuyasato associationbetweenserumalbuminandcognitivedysfunctioninhepaticencephalopathyanexploratorydataanalysis
AT masakifujisawa associationbetweenserumalbuminandcognitivedysfunctioninhepaticencephalopathyanexploratorydataanalysis
AT hitoshiyoshiji associationbetweenserumalbuminandcognitivedysfunctioninhepaticencephalopathyanexploratorydataanalysis